MedPath

ChanGes In Right ventricular volumes And Function Following diurEtic Treatment In Pulmonary arterial hypertension patients with decompensated right heart failure (GIRAFFE)

Completed
Conditions
pulmonary hypertension
right heart failure
10082206
10037454
Registration Number
NL-OMON44204
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

- Diagnosis of idiopathic PAH, hereditary PAH, drug- and toxins induced PAH or chronic thrombo-embolic PH (CTEPH), according to ESC/ERS pulmonary hypertension guidelines (15)
- Symptoms of decompensated right heart failure (ankle edema, ascites, weight gain) based on the assessment and the evaluation of the pulmonologist for which an up-titration of the diuretics is indicated
- Age >=18 and <=80 years
- Able to understand and willing to sign the Informed Consent Form

Exclusion Criteria

- Pregnant subjects
- Claustrophobia
- Inability to provide informed consent
- Change in PAH specific therapy during or the 3 months before the up-titration of diuretics
- Change in (dose) of any other medication.
- One or more of the following co-morbidities:, uncontrolled systemic hypertension (>140/90 mmHg) , renal failure (eGFR <30), recent diagnosis of pulmonary embolism (within 6 months).
- Contraindication for CMR imaging:
o Claustrophobia
o Implanted cardiac defibrillator or pacemaker
o Cochlear implant
o Others
- PH of any cause other than permitted in the entry criteria
- Known history of noncompliance considering therapies

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Change in stroke volume (SV) , Change in right ventricular ejection fraction<br /><br>(RVEF) (%), Change in right ventricular end diastolic volume (RVEDV) (ml),<br /><br>Change in right ventricular end systolic volume (RVESV) (ml), Change in right<br /><br>atrial pressure (RAP),volume, Change in right ventricular strain.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>nvt</p><br>
© Copyright 2025. All Rights Reserved by MedPath